Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Health Catalyst, Inc.HCAT · Entity 1565 | Director | June 10, 2021 | June 14, 2021 |
| Huckleberry.ai, Inc.DOMO · Entity 6423 | Director | June 04, 2019 | June 24, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Health Catalyst, Inc.
Report date June 10, 2021 · Filed June 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,999 |
Reported balance
After 2021-06-10 transaction · row 1
1 source rowRow 1 · 2021-06-10 · Grant · Acquired 3,285 · Balance 44,999 F1: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) June 10, 2022 and (ii) the date of the next Annual Meeting of the Issuer's Stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) June 10, 2022 and (ii) the date of the next Annual Meeting of the Issuer's Stockholders.
Huckleberry.ai, Inc.
Report date June 04, 2019 · Filed June 24, 2020 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table I · non-derivative | Direct | 20,784 |
Reported balance
Holding disclosure · report date 2019-06-04 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 20,784 F1: On June 6, 2019, a Form 4 was mistakenly filed on behalf of the Reporting Person, reporting an award of 4,699 Restricted Stock Units. As of June 6, 2019, the Reporting Person directly held only 20,784 shares of Class B Common Stock of the Issuer. F2: Includes 783 shares of Class B Common Stock acquired as a zero-cost, pro rata distribution from Zetta Venture Partners I, L.P. |
| Class B Common StockSEC Table I · non-derivative | IndirectSee footnote | 97,762 |
Reported balance
Holding disclosure · report date 2019-06-04 · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · Balance 97,762 F3: The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein. |
| Class B Common StockSEC Table I · non-derivative | IndirectSee footnote | 8,666 |
Reported balance
Holding disclosure · report date 2019-06-04 · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · Balance 8,666 F4: The reported securities are held directly by the Bullock Family 2003 Gift Trust. Jennifer Bullock serves as trustee to the Bullock Family 2003 Gift Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 2003 Gift Trust except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 6, 2019, a Form 4 was mistakenly filed on behalf of the Reporting Person, reporting an award of 4,699 Restricted Stock Units. As of June 6, 2019, the Reporting Person directly held only 20,784 shares of Class B Common Stock of the Issuer.
F2: Includes 783 shares of Class B Common Stock acquired as a zero-cost, pro rata distribution from Zetta Venture Partners I, L.P.
F3: The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein.
F4: The reported securities are held directly by the Bullock Family 2003 Gift Trust. Jennifer Bullock serves as trustee to the Bullock Family 2003 Gift Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 2003 Gift Trust except to the extent of any pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2021 Filed Jun 14, 2021 16:56 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 3,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004244 · primarydocument.xml · nonDerivative · entry 1 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,999 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) June 10, 2022 and (ii) the date of the next Annual Meeting of the Issuer's Stockholders. Read SEC document |
| December 04, 2020 Filed Dec 8, 2020 16:51 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 25,777 | $37.19 | $958,551.26 |
DisclosureSEC source: 0001562180-20-007110 · primarydocument.xml · nonDerivative · entry 1 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,714 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $37.00 to $37.44 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 02, 2020 Filed Oct 7, 2020 18:51 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,700 | $37.01 | $62,917.00 |
DisclosureSEC source: 0001562180-20-006319 · primarydocument.xml · nonDerivative · entry 1 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,491 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $37.00 to $37.03 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 16:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 423 | $37.00 | $15,651.63 |
DisclosureSEC source: 0001562180-20-006234 · primarydocument.xml · nonDerivative · entry 1 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,191 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $37.00 to $37.01 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 28, 2020 Filed Jul 29, 2020 17:33 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 400 | $37.00 | $14,800.00 |
DisclosureSEC source: 0001562180-20-005227 · primarydocument.xml · nonDerivative · entry 2 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,614 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 17:33 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,700 | $37.01 | $62,923.97 |
DisclosureSEC source: 0001562180-20-005227 · primarydocument.xml · nonDerivative · entry 1 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,014 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $37.00 to $37.02 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 12, 2020 Filed Jun 17, 2020 19:20 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 5,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004565 · primarydocument.xml · nonDerivative · entry 1 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,714 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the date of the next Annual Meeting of the Issuer's Stockholders. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 19:05 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 29,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001417 · primarydocument.xml · nonDerivative · entry 2 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,271 F1 · kind: Represents a pro rata distribution for no consideration. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 19:05 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 609,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001417 · primarydocument.xml · nonDerivative · entry 1 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: Represents a pro rata distribution for no consideration. F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of these shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 17:51 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 33,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001027 · primarydocument.xml · nonDerivative · entry 2 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,789 F3 · kind: Shares acquired by the Reporting Person pursuant to pro rata distributions for no consideration. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 17:51 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 609,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001027 · primarydocument.xml · nonDerivative · entry 1 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 609,143 F1 · kind: Represents a pro rata distribution for no consideration. F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| September 01, 2019 Filed Sep 3, 2019 19:51 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 3,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-004588 · primarydocument.xml · nonDerivative · entry 1 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,557 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the date of the next Annual Meeting of the Issuer's Stockholders. Read SEC document |
| July 29, 2019 Filed Jul 29, 2019 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | ConversionSeries D Preferred Stock · Derivative | 235,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-009171 · wf-form4_156444845692930.xml · derivative · entry 6 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 235,916 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F4 · price: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F4 · derivative.exercise_date: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F4 · derivative.expiration_date: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| July 29, 2019 Filed Jul 29, 2019 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | ConversionSeries C Preferred Stock · Derivative | 345,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-009171 · wf-form4_156444845692930.xml · derivative · entry 5 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 345,591 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F3 · price: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F3 · derivative.exercise_date: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F3 · derivative.expiration_date: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| July 29, 2019 Filed Jul 29, 2019 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | ConversionSeries B Preferred Stock · Derivative | 636,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-009171 · wf-form4_156444845692930.xml · derivative · entry 4 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 636,780 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F1 · price: Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F1 · derivative.exercise_date: Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F1 · derivative.expiration_date: Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| July 29, 2019 Filed Jul 29, 2019 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | ConversionCommon Stock | 235,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-009171 · wf-form4_156444845692930.xml · nonDerivative · entry 3 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,218,287 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| July 29, 2019 Filed Jul 29, 2019 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | ConversionCommon Stock | 345,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-009171 · wf-form4_156444845692930.xml · nonDerivative · entry 2 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 982,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| July 29, 2019 Filed Jul 29, 2019 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | ConversionCommon Stock | 636,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-009171 · wf-form4_156444845692930.xml · nonDerivative · entry 1 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 636,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 21:34 UTC | Huckleberry.ai, Inc. DOMO · Entity 6423 | GrantClass B Common Stock | 4,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-007679 · wf-form4_155987125635584.xml · nonDerivative · entry 1 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,483 F1 · shares: The shares are represented by restricted stock units ("RSU"s). Each RSU represents the Reporting Person's right to receive one share of Class B Common Stock of the Issuer, subject to the applicable vesting schedule. In the event the Reporting Person ceases to be a service provider, the unvested RSUs will be cancelled by the issuer F1 · price: The shares are represented by restricted stock units ("RSU"s). Each RSU represents the Reporting Person's right to receive one share of Class B Common Stock of the Issuer, subject to the applicable vesting schedule. In the event the Reporting Person ceases to be a service provider, the unvested RSUs will be cancelled by the issuer F2 · balance_after: 783 shares acquired as a zero-cost, pro rata distribution from Zetta Venture Partners I, L.P. Read SEC document |
| July 03, 2018 Filed Jul 3, 2018 20:18 UTC | Huckleberry.ai, Inc. DOMO · Entity 6423 | ConversionSeries C Preferred Stock · Derivative | 70,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-009098 · wf-form4_153066347844675.xml · derivative · entry 6 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class B Common Stock · 70,190 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date. F3 · derivative.exercise_date: Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date. F3 · derivative.expiration_date: Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date. F2 · ownership.nature: The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein. Read SEC document |
| July 03, 2018 Filed Jul 3, 2018 20:18 UTC | Huckleberry.ai, Inc. DOMO · Entity 6423 | ConversionSeries A Preferred Stock · Derivative | 18,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-009098 · wf-form4_153066347844675.xml · derivative · entry 5 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class B Common Stock · 18,783 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date. F3 · derivative.exercise_date: Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date. F3 · derivative.expiration_date: Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date. F2 · ownership.nature: The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein. Read SEC document |
| July 03, 2018 Filed Jul 3, 2018 20:18 UTC | Huckleberry.ai, Inc. DOMO · Entity 6423 | ConversionClass B Common Stock | 70,190 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-18-009098 · wf-form4_153066347844675.xml · nonDerivative · entry 3 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 97,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The reported securities are held directly by the Bullock Family 2003 Gift Trust. Jennifer Bullock serves as trustee to the Bullock Family 2003 Gift Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 2003 Gift Trust except to the extent of any pecuniary interest therein. F2 · ownership.nature: The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein. Read SEC document |
| July 03, 2018 Filed Jul 3, 2018 20:18 UTC | Huckleberry.ai, Inc. DOMO · Entity 6423 | ConversionClass B Common Stock | 18,783 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-18-009098 · wf-form4_153066347844675.xml · nonDerivative · entry 2 Bullock D Fraser · CIK 0001366853 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 27,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The reported securities are held directly by the Bullock Family 2003 Gift Trust. Jennifer Bullock serves as trustee to the Bullock Family 2003 Gift Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 2003 Gift Trust except to the extent of any pecuniary interest therein. F2 · ownership.nature: The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.